In the current study, we reveal that nuclear C3b acts as a cofactor of the chromatin remodeling SIN3A complex to repress the expression of GADD45A, thus conferring acquired resistance of lung cancer to PTX treatment. This evidence concerns the gene SIN3A and lung cancer.